BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 6806138)

  • 1. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
    Jansen JB; Lamers CB
    Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
    Mihas AA; Hirschowitz BI; Gibson RG
    Digestion; 1978; 17(1):1-10. PubMed ID: 627316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of secretin on plasma gastrin in the Zollinger-Ellison syndrome.
    Schrumpf E; Petersen H; Berstad A; Myren J; Rosenlund B
    Scand J Gastroenterol; 1973; 8(2):145-50. PubMed ID: 4697075
    [No Abstract]   [Full Text] [Related]  

  • 4. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
    Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
    Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of stress on serum gastrin in Zollinger-Ellison syndrome.
    Nomura T; Fukudo S; Muranaka M; Iwahashi S; Sasaki M; Satake M; Sasaki I; Shibata C; Matsuno S
    Am J Gastroenterol; 1993 Sep; 88(9):1432-5. PubMed ID: 8362843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome.
    Thompson JC; Reeder DD; Villar HV; Fender HR
    Surg Gynecol Obstet; 1975 May; 140(5):721-39. PubMed ID: 1145407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin and gastric surgery.
    Fabri PJ; McGuigan JE
    Major Probl Clin Surg; 1976; 20():92-105. PubMed ID: 957787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and calcium-stimulated gastroesophageal sphincter pressure in patients with Zollinger-Ellison syndrome.
    Snyder N; Hughes W
    Gastroenterology; 1977 Jun; 72(6):1240-3. PubMed ID: 858470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
    Lamers CG; Van Tongeren JH
    Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome.
    Isenberg JI; Walsh JH; Passaro E; Moore EW; Grossman MI
    Gastroenterology; 1972 Apr; 62(4):626-31. PubMed ID: 5020875
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of secretin on gastrin release from gastrinoma cells in vitro.
    Elkhammas EA; Gower WR; Woltering EA; O'Dorisio TM; Sparks J; Fabri PJ; Ellison EC
    Surgery; 1986 Dec; 100(6):948-53. PubMed ID: 3787478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity, specificity and predictive values of the secretin infusion test in the diagnosis of gastrinoma.
    Poynard T; Mignon M; Accary JP; Bonfils S
    Gastroenterol Clin Biol; 1986; 10(6-7):492-6. PubMed ID: 3758593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and precision of serum gastrin measurements in commercial laboratories.
    Notar-Francesco V; Samuel S; Kanakamedala S; Straus EW
    J Assoc Acad Minor Phys; 1995; 6(4):130-3. PubMed ID: 8520176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the diagnosis and treatment of Zollinger-Ellison syndrome (author's transl)].
    Feurle GE; Helmstädter V; Hoevels J; Wenzel-Herzer G; Klempa I
    Dtsch Med Wochenschr; 1982 May; 107(18):697-704. PubMed ID: 7075486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gastrin release by acute changes in plasma calcium.
    Wiersinga WM; Schellekens AP; Thornton WE; Touber JL; Tijtgat GN
    Digestion; 1978; 18(3-4):290-3. PubMed ID: 104896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol on secretin-induced gastrin release and secretin-induced tachycardia in patients with the Zollinger-Ellison syndrome.
    Goldschmeidt M; Redfern JS; Feldman M
    Aliment Pharmacol Ther; 1990 Aug; 4(4):325-31. PubMed ID: 2103752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients.
    Dockray GJ; Walsh JH
    Gastroenterology; 1975 Feb; 68(2):222-30. PubMed ID: 1116670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.